1. Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction. (12th April 2023) Authors: Santos-Gallego, Carlos G.; Requena-Ibáñez, Juan Antonio; Picatoste, Belen; Fardman, Brian; Ishikawa, Kiyotake; Mazurek, Renata; Pieper, Michael; Sartori, Samantha; Rodriguez-Capitán, Jorge; Fuster, Valentin; Badimon, Juan J. Journal: Circulation Issue: Volume 16:Number 4(2023) Page Start: e015298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy. (1st September 2020) Authors: Garcia-Ropero, Alvaro; Santos-Gallego, Carlos G.; Vargas-Delgado, Ariana P.; Requena-Ibanez, Juan Antonio; Picatoste, Belen; Ishikawa, Kiyotake; Sanz, Javier; Tunon, Jose; Badimon, Juan J. Journal: Expert review of cardiovascular therapy Issue: Volume 18:Number 9(2020) Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion. Issue 10 (8th March 2016) Authors: Santos-Gallego, Carlos G.; Vahl, Torsten P.; Goliasch, Georg; Picatoste, Belen; Arias, Teresa; Ishikawa, Kiyotake; Njerve, Ida U.; Sanz, Javier; Narula, Jagat; Sengupta, Partho P.; Hajjar, Roger J.; Fuster, Valentin; Badimon, Juan J. Journal: Circulation Issue: Volume 133:Issue 10(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗